| Literature DB >> 33303019 |
Sina Naserian1,2,3, Sara Shamdani4,5,6, Nassim Arouche4,5, Georges Uzan4,5.
Abstract
Mesenchymal stem/stromal cells can modulate the effector immune cells especially T lymphocytes. Due to this important feature, they can regulate the development of a variety of disorders including inflammatory and autoimmune disorders, cancers, and transplantation outcomes. One of the most important MSC immunoregulatory functions is their capacity to convert conventional T cells into regulatory T cells. Several mechanisms, mostly related to MSCs but not T cells, have been shown essential for this aspect. The inflammatory microenvironment majorly caused by pro-inflammatory cytokines has been demonstrated to govern the direction of the immune response. In this respect, we have recently revealed that the TNFα-TNFR2 signaling controls several aspects of MSC immunomodulatory properties including their ability to suppress T cells and their conversion towards Foxp3-expressing Tregs. Here in this work, we have looked from another angle by investigating the impact of TNFR2 expression by T cells on their ability to be converted to suppressive Tregs by MSCs. We showed that unlike WT-T cells, their TNFR2 KO counterparts are remarkably less able to convert into Foxp3+ and Foxp3- Tregs. Furthermore, TNFR2 blockade diminished the anti-inflammatory cytokine secretion by iTregs and consequently resulted in less T cell immunosuppression. This work is the first evidence of the crucial association of TNFR2 expression by T cells with their iTreg conversion capacity by MSCs. It strengthens once more the potential of anti-TNFR2 administration for a strong and effective interference with the immunosuppression exerted by TNFR2-expressing cells.Entities:
Keywords: Immune checkpoint; Immune therapy; Immunoregulation; Immunosuppression; Mesenchymal stem cells; Regulatory T cells; TNF-TNFR2 signaling pathway
Mesh:
Substances:
Year: 2020 PMID: 33303019 PMCID: PMC7731479 DOI: 10.1186/s13287-020-02057-z
Source DB: PubMed Journal: Stem Cell Res Ther ISSN: 1757-6512 Impact factor: 6.832
Fig. 1MSC characterization and the schematic representation of the experimental procedures. a MSCs isolated from the bone marrow of WT mice were first evaluated for the expression of mouse MSC characterization markers. Cells were gated on total MSCs for evaluation of CD44 marker. For the rest of the markers, cells were first gated on CD44+ cells. Red histograms depict the isotype controls, and blue histograms depict the expression of each desired marker. Thereafter, MSCs were co-cultured with b WT-T cells and c TNFR2 KO-T cells for further experimental procedures. d These FACS representatives demonstrate the depletion of CD25+ subpopulation from initial T cells
Fig. 2TNFR2 expression by T cells is directly associated with the Foxp3 upregulation by MSCs. MSCs were co-cultured with six increasing doses (1:1 to 1:10) of WT and TNFR2 KO-T cells for a duration of 3 days. a Then, they were collected and analyzed by flow cytometry for the expression of the Foxp3 molecule. WT or TNFR2 KO CD3+CD25− T cells were used as control T cells alone. The white columns depict WT or TNFR2 KO-T cells cultured alone. The black columns depict WT-T cells co-cultured with WT-MSCs, while gray columns represent TNFR2 KO-T cells co-cultured with WT-MSCs. b These FACS plots and histograms demonstrate our T cell gating strategy revealing a dose-dependent upregulation of the Foxp3 transcription factor among WT-T cells. Data are representative of two separate experiments (n = 8)
Fig. 3TNFR2 expression by T cells is directly associated with the secretion of anti-inflammatory cytokines and their immunosuppressive effect. a The secretion of IL-10 and TGFβ anti-inflammatory cytokines was assessed by the ELISA method. Total T cells collected after co-culturing with WT-MSCs were further activated or not with anti-CD3/CD28 beads for a duration of 24 h. Furthermore, Treg immunosuppressive effect was measured by performing an MLR test. Briefly, 104 MSC-exp T cells were added to 105 freshly isolated CFSE-labeled responder T cells. Responder cells were activated using anti-CD3/CD28 beads. After 3 days, the proliferation capacity of b CD4+ and c CD8+ T cell subsets was analyzed by flow cytometry (n = 4). FACS histograms demonstrate flow cytometry representatives of the proliferation assay